The Cooper Companies Inc (FRA:CP60)
€ 93.95 0.55 (0.59%) Market Cap: 18.74 Bil Enterprise Value: 21.08 Bil PE Ratio: 51.11 PB Ratio: 2.46 GF Score: 94/100

Cooper Companies Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 06:45PM GMT
Release Date Price: €71.5
Marissa Elizabeth Bych
Morgan Stanley, Research Division - Research Associate

Good morning for those of you on the West Coast and good afternoon for those on the East Coast. This is Marissa Bych with Morgan Stanley medtech equity research. And I'm back again with now, Brian Andrews, the CFO and Treasurer of Cooper Companies; and Kim Duncan, the VP of Investor Relations. Brian and Kim, it's great to have you with us. I think this is the first time we've had you for a live presentation at our Morgan Stanley healthcare conference. So hopefully, the first of many and hopefully in person next year. We'll see. But great to have you here.

Questions & Answers

Marissa Elizabeth Bych
Morgan Stanley, Research Division - Research Associate

There are a number of dynamics, I think, we should talk about today. We can talk about kind of near-term COVID-19 recovery and then some of the new product launches. MiSight, most importantly, has been a focus. And maybe get into some of the financials as well.

But let's just start with the nearer term, if that's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot